Arbutus Biopharma Corp
ABUS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001447028
No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Arbutus Biopharma Corp changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 122 | 1 | 111 | −10 |
| Shares | 62.5M | 52.0K | 66.2M | +3.80M (+6.1%) |
| Value | $189.3M | $157.4K | $152.4M | −$36.7M (−19.4%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Arbutus Biopharma Corp at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jefferies Financial Group Inc. | 264,441 | $608.2K | 0.01% |
| Kepos Capital LP | 200,000 | $460.0K | 0.08% |
| State Board of Administration of Florida Retirement System | 35,430 | $81.5K | 0.00% |
| Man Group plc | 24,500 | $56.4K | 0.00% |
| Two Sigma Advisers, LP | 13,700 | $31.5K | 0.00% |
| American Century Companies Inc | 10,660 | $24.5K | 0.00% |
| Credit Agricole S A | 7,750 | $17.8K | 0.00% |
| US Bancorp | 1,909 | $4.39K | 0.00% |
| Richard W. Paul & Associates, LLC | 379 | $872 | 0.00% |
| Key Financial Inc | 322 | $741 | 0.00% |
| Allspring Global Investments Holdings, LLC | 95 | $218 | 0.00% |
| Crewe Advisors LLC | 56 | $129 | 0.00% |
Sold out (22)
Institutions that held Arbutus Biopharma Corp at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Wellington Management Group LLP | 279,832 | $847.9K |
| Jane Street Group, LLC | 136,288 | $413.0K |
| Cubist Systematic Strategies, LLC | 119,193 | $361.2K |
| Alps Advisors Inc | 107,107 | $324.5K |
| Jump Financial, LLC | 68,974 | $209.0K |
| SG Americas Securities, LLC | 52,397 | $159.0K |
| Rafferty Asset Management, LLC | 31,693 | $96.0K |
| Franklin Resources Inc | 31,436 | $95.3K |
| CM Wealth Advisors LLC | 37,096 | $94.0K |
| Verition Fund Management LLC | 25,371 | $76.9K |
| Two Sigma Securities, LLC | 21,235 | $64.3K |
| Kades & Cheifetz LLC | 20,000 | $60.6K |
| Dark Forest Capital Management LP | 17,155 | $52.0K |
| Ergoteles LLC | 15,000 | $45.5K |
| Virtu Financial LLC | 12,208 | $37.0K |
| Apollon Wealth Management, LLC | 11,725 | $35.5K |
| State of Wyoming | 11,005 | $33.3K |
| Sawtooth Solutions, LLC | 10,813 | $32.8K |
| Bleakley Financial Group, LLC | 10,813 | $32.8K |
| GPS Wealth Strategies Group, LLC | 700 | $2.12K |
| TCI Wealth Advisors, Inc. | 500 | $1.51K |
| Quadrant Capital Group LLC | 205 | $622 |
Not filed for Q2 2023 yet (1)
Institutions that held Arbutus Biopharma Corp at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| ETF Managers Group, LLC | 51,963 | $157.4K |